SEC Form 4 · accession 0000899243-18-019325
Translate Bio, Inc. · TBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
MRL Ventures Fund LLC
10% Owner
Period of report
Jul 2, 2018
Accepted (ET)
Jul 3, 2018 · 6:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001693415
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 2, 2018 | C | 1,848,503 | — | A | 1,848,503 | D | |
| Common Stock | Jul 2, 2018 | P | 25,000 | $13.00 | A | 1,873,503 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Preferred StockF1 | — | Jul 2, 2018 | C | 9,259,259 | D | — | — | Common Stock | 1,666,683 | 0 | D |
| Series C Preferred StockF1 | — | Jul 2, 2018 | C | 1,010,101 | D | — | — | Common Stock | 181,819 | 0 | D |
Explanation of responses
- F1The Series B and Series C Preferred Stock converted into Common Stock on a 5.5555-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.